Julian Robertson Adaptive Biotechnologies Corp Transaction History

Tiger Management L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $3.77 Million - $8.68 Million	-589,311 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $5.32 Million - $15.2 Million	-526,100 Reduced 47.17%	589,311 $8.18 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $33.8 Million - $59.7 Million	1,115,411 New	1,115,411 $34.5 Million

251

151M

44.3K

47.8K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.58B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.